MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s13058-022-01575-3

Медицинская библиотека · Breast cancer research : BCR · 2022

Associations of aspirin and other anti-inflammatory medications with breast cancer risk by the status of COX-2 expression.

Yaghjyan Lusine, Eliassen A Heather, Colditz Graham, Rosner Bernard, Schedin Pepper, Wijayabahu Akemi, Tamimi Rulla M

СтатьяПеревод в очереди

Аннотация

BACKGROUND

We investigated the associations of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) with breast cancer risk by the status of COX-2 protein expression.

METHODS

This study included 421 cases and 3,166 controls from a nested case-control study within the Nurses' Health Study (NHS) and Nurses' Health Study II (NHSII) cohorts. Information on medication use was first collected in 1980 (NHS) and 1989 (NHSII) and was updated biennially. Medication use was defined as none, past or current; average cumulative dose and frequency were calculated for all past or current users using data collected from all biannual questionnaires preceding the reference date. Immunochemistry for COX-2 expression was performed using commercial antibody (Cayman Chemical and Thermo Fisher Scientific). We used polychotomous logistic regression to quantify associations of aspirin and NSAIDs with the risk of COX2+ and COX2- breast cancer tumors, while adjusting for known breast cancer risk factors. All tests of statistical significance were two-sided.

RESULTS

In multivariate analysis, we found no differences in associations of the aspirin exposures and NSAIDs with breast cancer risk by COX2 expression status. In stratified analyses by COX2 status, significant associations of these medications with breast cancer risk were observed for dosage of aspirin among current users in COX2- tumors (OR for > 5 tablets per week vs. none 1.71, 95% CI 1.01-2.88, p-trend 0.04). Regular aspirin use was marginally associated with the risk of COX2- tumors (p-trend = 0.06).

CONCLUSIONS

Our findings suggested no differences in associations of aspirin and other NSAIDs with COX2+ and COX2- tumors.

Для цитирования: Yaghjyan Lusine, Eliassen A Heather, Colditz Graham, Rosner Bernard, Schedin Pepper, Wijayabahu Akemi, Tamimi Rulla M. Associations of aspirin and other anti-inflammatory medications with breast cancer risk by the status of COX-2 expression.. Breast cancer research : BCR. 2022. DOI: 10.1186/s13058-022-01575-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.